Literature DB >> 18799721

Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.

Nina Babel1, Gordon Brestrich, Lukasz P Gondek, Arne Sattler, Marcin W Wlodarski, Nina Poliak, Nicole Bethke, Andreas Thiel, Markus H Hammer, Petra Reinke, Jaroslaw P Maciejewski.   

Abstract

Cytotoxic T lymphocytes (CTL) control the replication of human cytomegalovirus (CMV). Previous studies assessed the clonotypic composition of CTL specific for individual immunodominant peptides within a certain HLA context. Such an approach has inherent limitations and may not assess the true clonal CTL response in vivo. Here, the clonotypic composition of CMV-specific CTL was determined in HLA-A2, CMV-seropositive kidney transplant recipients and healthy blood donors after stimulation of peripheral blood mononuclear cells with either a pp65 whole-peptide pool or a single immunodominant peptide. Even after stimulation with the whole peptide pool, CMV-specific CTL remained monoclonal or oligoclonal. Regarding intraindividual variation, the CDR3 motifs of the dominant clones were identical to those observed in CTL generated by the single immunodominant peptide. Sequencing of the CDR3 regions demonstrated significant interindividual variation; however, structural homology was observed for immunodominant clonotypes in three individuals. In conclusion, the highly focused T cell receptor repertoire found after stimulation with either a single immunodominant peptide or a peptide pool demonstrates a pivotal role for immunodominant epitopes in the generation of a clonal repertoire. These results provide new insights into the regulation of CMV clonal dominance and may contribute to the design and monitoring of adoptive immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799721      PMCID: PMC2637041          DOI: 10.1681/ASN.2007111225

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  26 in total

1.  Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant.

Authors:  P S Heeger; T Forsthuber; C Shive; E Biekert; C Genain; H H Hofstetter; A Karulin; P V Lehmann
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.

Authors:  Naeem Khan; Naseer Shariff; Mark Cobbold; Rachel Bruton; Jenni A Ainsworth; Alan J Sinclair; Laxman Nayak; Paul A H Moss
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

3.  A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

Authors:  Y Sun; E Iglesias; A Samri; G Kamkamidze; T Decoville; G Carcelain; B Autran
Journal:  J Immunol Methods       Date:  2003-01-15       Impact factor: 2.303

4.  Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.

Authors:  Karl Peggs; Stephanie Verfuerth; Arnold Pizzey; Jenni Ainsworth; Paul Moss; Stephen Mackinnon
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

5.  Large granular lymphocyte leukaemia is characterized by a clonal T-cell receptor rearrangement in both memory and effector CD8(+) lymphocyte populations.

Authors:  J J Melenhorst; L Sorbara; M Kirby; N F Hensel; A J Barrett
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

6.  Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype.

Authors:  M R Betts; J P Casazza; B A Patterson; S Waldrop; W Trigona; T M Fu; F Kern; L J Picker; R A Koup
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.

Authors:  F Kern; N Faulhaber; C Frömmel; E Khatamzas; S Prösch; C Schönemann; I Kretzschmar; R Volkmer-Engert; H D Volk; P Reinke
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

8.  Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome.

Authors:  Marcin W Wlodarski; Lukasz P Gondek; Zachary P Nearman; Magdalena Plasilova; Matt Kalaycio; Eric D Hsi; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2006-04-13       Impact factor: 22.113

9.  Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection.

Authors:  Katja Kotsch; Mir Farzin Mashreghi; Gantuja Bold; Philipp Tretow; Jana Beyer; Mareen Matz; Jan Hoerstrup; Johann Pratschke; Ruchuang Ding; Manikkam Suthanthiran; Hans-Dieter Volk; Petra Reinke
Journal:  Transplantation       Date:  2004-06-27       Impact factor: 4.939

10.  T cell recognition patterns of immunodominant cytomegalovirus antigens in primary and persistent infection.

Authors:  Naeem Khan; Donna Best; Rachel Bruton; Laxman Nayak; Alan B Rickinson; Paul A H Moss
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

View more
  11 in total

1.  Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire.

Authors:  Ryan O Emerson; William S DeWitt; Marissa Vignali; Jenna Gravley; Joyce K Hu; Edward J Osborne; Cindy Desmarais; Mark Klinger; Christopher S Carlson; John A Hansen; Mark Rieder; Harlan S Robins
Journal:  Nat Genet       Date:  2017-04-03       Impact factor: 38.330

Review 2.  T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.

Authors:  Rebecca J Watters; Xin Liu; Thomas P Loughran
Journal:  Leuk Lymphoma       Date:  2011-07-13

3.  Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age.

Authors:  Raymond P Stowe; M Kristen Peek; Malcolm P Cutchin; James S Goodwin
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

Review 4.  Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.

Authors:  Charles H Cook; Joanne Trgovcich
Journal:  Antiviral Res       Date:  2011-03-23       Impact factor: 5.970

5.  Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.

Authors:  Brooke E Mcbreairty; Boris I Chobrutskiy; Andrea Chobrutskiy; Etienne C Gozlan; Michael J Diaz; George Blanck
Journal:  Biomed Rep       Date:  2022-06-09

6.  Multiple modes of antigen exposure induce clonotypically diverse epitope-specific CD8+ T cells across multiple tissues in nonhuman primates.

Authors:  Jennifer Simpson; Carly E Starke; Alexandra M Ortiz; Amy Ransier; Sam Darko; Daniel C Douek; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2022-07-07       Impact factor: 7.464

7.  Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.

Authors:  Meghan R Forster; Joanne Trgovcich; Peter Zimmerman; Alexander Chang; Cortland Miller; Paul Klenerman; Charles H Cook
Journal:  Antiviral Res       Date:  2009-12-11       Impact factor: 5.970

8.  Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.

Authors:  H Nakasone; Y Tanaka; R Yamazaki; K Terasako; M Sato; K Sakamoto; R Yamasaki; H Wada; Y Ishihara; K Kawamura; T Machishima; M Ashizawa; S-I Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

9.  Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cells.

Authors:  Mark Klinger; Katherine Kong; Martin Moorhead; Li Weng; Jianbiao Zheng; Malek Faham
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

10.  Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing.

Authors:  Mark Klinger; Francois Pepin; Jen Wilkins; Thomas Asbury; Tobias Wittkop; Jianbiao Zheng; Martin Moorhead; Malek Faham
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.